Searched for
PHARMA LOBBY OBJECTIONS
Stricter shelf life rule a bitter pill to swallow for pharma companiesA new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the I...- Pharma lobby flags 'cumbersome' export rule, seeks changePharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...
- Pharma companies may lose licence if drugs fail testsThe health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...
- Panel to examine if nutraceuticals can be produced within drug unitIn a significant development, a five-member expert committee has been appointed to assess the feasibility of allowing the manufacturing of ...
- Lens on cos making drugs, supplements in same facility: Pharma body hopeful of a rethink on govt actionIn a recent diktat, the government said action will be taken against pharma units that are flouting the norms by manufacturing nutraceutica...
- Pharma department briefs PMO on trade margin rationalisation"A presentation was made to the PMO in this regard and the concern of the Laghu Udyog Bharati was also discussed. A decision is likely to b...
- Soon, interest subsidy on loans for pharmaceutical infrastructure, technology upgradesThe Department of Pharmaceuticals proposes to bear 6% of the interest on loans up to Rs 8-10 crore for three years, through a public sector...
- CBI arrests Deputy Drug Controller over graft chargeNaresh Sharma joined the CDSCO in November 2006, from Dabur Research Foundation. His past work experiences have involved stints with Cadila...
- CBI arrests Deputy Drug Controller over graft chargesDr. Naresh Sharma, Deputy Drug Controller of the Central Drugs Standard Control Organisation has been suspended with immediate effect.
- Pharma majors knock at Niti Aayog's doors with concerns over new drug policyDrug companies have also objected to mandatory quality control BA/BE tests for all drugs, including for future renewals of manufacturing li...
- Foreign pharma firms make pitch for easing FDI normsAhead of US President Barack Obama’s visit, OPPI has urged govt to allow inclusion of non-complete clauses when it comes to M&As.
- US industry patent lobby meeting with judges foiledPublic health groups successfully prevented meetings that had been scheduled between a visiting delegation of a US industry patent grouping...
- Cabinet Secretary Ajit Seth calls meet of top officials on India-US pharmaceuticals issueIndian Ambassador to US S Jaishankar has suggested that the Indian government should engage with US pharma firms to deliberate on the matte...
- India may take US to WTO if included in priority country listIndia is likely to drag the US to WTO if America includes it in the 'Priority Foreign Country' list for intellectual property rights.
- Doctors association slams US for pressuring India on pharma patent lawsA Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting pressure on India over its patent law...
- New pharma pricing policy to cost manufacturers Rs 1,500 crore: StudyThe proposed national drug pricing policy will cost drugmakers close to 1,500 crore and stockists and traders collectively over 2,500 crore...
- Azad resents to lobbying against patent laws by MNCsHealth minister has objected to recent lobbying attempts by global drugmakers to change India's intellectual property rules.
- India may take up Ranbaxy ban issue with the USGovt would step in if the USFDA refused to revoke the ban despite procedural corrections being taken by Ranbaxy at its manufacturing facili...
- Delay in amending patents law adds to worries over modalitiesThe government's inability to amend the patents law during the winter session of the Parliament has led to apprehensions over the modalitie...
- Ambiguity over changes in patents lawThe government's inability to amend the patents law during the winter session of Parliament has led to apprehensions over the modalities re...
Load More
